Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Non Operating Income (2018 - 2025)

Rockwell Medical (RMTI) has disclosed Non Operating Income for 8 consecutive years, with -$169000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non Operating Income rose 37.87% year-over-year to -$169000.0, compared with a TTM value of -$704000.0 through Sep 2025, up 61.23%, and an annual FY2024 reading of -$1.1 million, up 38.5% over the prior year.
  • Non Operating Income was -$169000.0 for Q3 2025 at Rockwell Medical, down from -$143000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at -$135000.0 in Q3 2023 and bottomed at -$965000.0 in Q4 2023.
  • Average Non Operating Income over 5 years is -$397947.4, with a median of -$396000.0 recorded in 2022.
  • The sharpest move saw Non Operating Income tumbled 902.82% in 2021, then soared 75.44% in 2024.
  • Year by year, Non Operating Income stood at -$582000.0 in 2021, then soared by 31.96% to -$396000.0 in 2022, then plummeted by 143.69% to -$965000.0 in 2023, then skyrocketed by 75.44% to -$237000.0 in 2024, then increased by 28.69% to -$169000.0 in 2025.
  • Business Quant data shows Non Operating Income for RMTI at -$169000.0 in Q3 2025, -$143000.0 in Q2 2025, and -$155000.0 in Q1 2025.